Literature DB >> 27755870

C3 Epimerization of Glucose, via Regioselective Oxidation and Reduction.

Varsha R Jumde1, Niek N H M Eisink1, Martin D Witte1, Adriaan J Minnaard1.   

Abstract

Palladium-catalyzed oxidation can single out the secondary hydroxyl group at C3 in glucose, circumventing the more readily accessible hydroxyl at C6 and the more reactive anomeric hydroxyl. Oxidation followed by reduction results in either allose or allitol, each a rare sugar that is important in biotechnology. Also, N-acetylglucosamine is selectively oxidized at C3. These results demonstrate that glucose and N-acetylglucosamine, the most readily available chiral building blocks, can be versatile substrates in homogeneous catalysis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27755870     DOI: 10.1021/acs.joc.6b02074

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Optimization for allitol production from D-glucose by using immobilized glucose isomerase and recombinant E. coli expressing D-psicose-3-epimerase, ribitol dehydrogenase and formate dehydrogenase.

Authors:  Xin Wen; Huibin Lin; Yilin Ren; Can Li; Chengjia Zhang; Xin Song; Jianqun Lin; Jianqiang Lin
Journal:  Biotechnol Lett       Date:  2020-05-25       Impact factor: 2.461

2.  Regioselective Carbohydrate Oxidations: A Nuclear Magnetic Resonance (NMR) Study on Selectivity, Rate, and Side-Product Formation.

Authors:  Niek N H M Eisink; Martin D Witte; Adriaan J Minnaard
Journal:  ACS Catal       Date:  2017-01-18       Impact factor: 13.084

3.  Selective Modification of Streptozotocin at the C3 Position to Improve Its Bioactivity as Antibiotic and Reduce Its Cytotoxicity towards Insulin-Producing β Cells.

Authors:  Ji Zhang; Liubov Yakovlieva; Bart J de Haan; Paul de Vos; Adriaan J Minnaard; Martin D Witte; Marthe T C Walvoort
Journal:  Antibiotics (Basel)       Date:  2020-04-15

Review 4.  Site-Selective Modification of (Oligo)Saccharides.

Authors:  Martin D Witte; Adriaan J Minnaard
Journal:  ACS Catal       Date:  2022-09-23       Impact factor: 13.700

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.